DrugPatentWatch Database Preview
Sunovion Resp Company Profile
What is the competitive landscape for SUNOVION RESP, and when can generic versions of SUNOVION RESP drugs launch?
SUNOVION RESP has one approved drug.
There are nine US patents protecting SUNOVION RESP drugs.
There are sixty-five patent family members on SUNOVION RESP drugs in thirteen countries.
Summary for Sunovion Resp
| International Patents: | 65 |
| US Patents: | 9 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Sunovion Resp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunovion Resp | LONHALA MAGNAIR KIT | glycopyrrolate | SOLUTION;INHALATION | 208437-001 | Dec 5, 2017 | RX | Yes | Yes | 9,168,556 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Sunovion Resp | LONHALA MAGNAIR KIT | glycopyrrolate | SOLUTION;INHALATION | 208437-001 | Dec 5, 2017 | RX | Yes | Yes | 9,265,900 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Sunovion Resp | LONHALA MAGNAIR KIT | glycopyrrolate | SOLUTION;INHALATION | 208437-001 | Dec 5, 2017 | RX | Yes | Yes | 9,604,018 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Sunovion Resp Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 4176016 | ➤ Try a Free Trial |
| Japan | 2009125590 | ➤ Try a Free Trial |
| European Patent Office | 2437896 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
